Palbociclib (PD 0332991) is an orally active selective CDK4 and CDK6 inhibitor with IC50 values of 11 and 16 nM, respectively. Palbociclib has potent anti-proliferative activity and induces cell cycle arrest in cancer cells, which can be used in the research of HR-positive and HER2-negative breast cancer and hepatocellular carcinoma[1][3][4].
Molecular Weight:
447.53
Purity:
99.97
CAS Number:
[571190-30-2]
Formula:
C24H29N7O2
Target:
CDK
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted